Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada M5T 1R8.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1412-8. doi: 10.1016/j.pnpbp.2010.07.019. Epub 2010 Jul 24.
Schizophrenia (SCZ) is a severe neuropsychiatric disorder with prominent genetic etiologic factors. The dopamine receptor DRD3 gene is a strong candidate in genetic studies of SCZ because of the dopamine hypothesis of SCZ and the selective expression of D(3) in areas of the limbic system implicated in the disease. We examined 15 single-nucleotide polymorphisms (SNPs) in DRD3 in our sample of European origin consisting of 95 small nuclear SCZ families and 167 case-control pairs. We also examined four BDNF SNPs in our samples because of evidence for BDNF regulation of DRD3 expression (Guillin et al., 2001). We found a nominally significant genotypic association with rs7633291 and allelic association with rs1025398 alleles. However, these observations did not survive correction for multiple testing. We did not find a statistically significant association with the other DRD3 and BDNF polymorphisms. Taken together, the results from the present study suggest that BDNF and DRD3 may not be involved in SCZ susceptibility.
精神分裂症 (SCZ) 是一种严重的神经精神疾病,具有明显的遗传病因。多巴胺受体 DRD3 基因是 SCZ 遗传研究的一个强有力的候选基因,因为多巴胺假说和 D(3)在与疾病相关的边缘系统区域的选择性表达。我们在由 95 个小核 SCZ 家族和 167 个病例对照对组成的欧洲样本中检查了 DRD3 的 15 个单核苷酸多态性 (SNP)。我们还检查了我们样本中的四个 BDNF SNPs,因为有证据表明 BDNF 调节 DRD3 的表达 (Guillin 等人,2001 年)。我们发现 rs7633291 的基因型与 rs1025398 等位基因具有显著的关联,但这些观察结果在经过多次测试校正后并未成立。我们没有发现与其他 DRD3 和 BDNF 多态性的统计学显著关联。总的来说,本研究的结果表明 BDNF 和 DRD3 可能不参与 SCZ 的易感性。